Article(id=1329835095424348687, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.02.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1692547200000, receivedDateStr=2023-08-21, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794986993890, onlineDateStr=2026-11-18, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794986993890, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794986993890, creator=13701087609, updateTime=1794986993890, updator=13701087609, issue=Issue{id=1329835073559441697, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='2', pageStart='107', pageEnd='227', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794986988677, creator='13701087609', updateTime=1794988212209, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329840205898560208, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329840205902754513, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=112, endPage=118, ext={EN=ArticleExt(id=1329835097152401936, articleId=1329835095424348687, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Application of progesterone in preserving fertility in endometrial cancer and atypical endometrial hyperplasia, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

The onset of endometrial cancer and atypical endometrial hyperplasia is gradually becoming younger, and the current childbearing age is generally delayed, which makes these patients have a great demand for fertility sparing treatment. As the second most common gynecological malignancy in China, the standard treatment is total hysterectomy and bilateral adnexectomy, which leads to permanent infertility. Progesterone is effective in the treatment of early-stage endometrial cancer and atypical endometrial hyperplasia without destroying fertility. Screening criteria for these patients have been recommended in guidelines. Oral megestrol acetate and medroxyprogesterone acetate are the most commonly used fertility sparing treatments, levonorgestrel-releasing intrauterine devices, as a local progesterone therapy, can not be ignored. In addition, studies on the combination of progesterone drugs with metformin and gonadotropin releasing hormone agonist are being carried out. Facing the limitations of existing treatment options, it is equally important to actively search for therapeutic and prognostic markers, and explore new treatment methods.

, authors=Junmin LI, Jialei ZHU, Jing TANG*, authorsList=Junmin LI, Jialei ZHU, Jing TANG, authorCompany=null, correspAuthors=Jing TANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835097475363345, articleId=1329835095424348687, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=孕激素在子宫内膜癌和非典型子宫内膜增生保留生育力中的应用, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

子宫内膜癌(endometrial cancer)和非典型子宫内膜增生(atypical endometrial hyperplasia)患者的发病逐渐年轻化,当前生育年龄又普遍延迟,使得这类患者对保留生育力的治疗产生重大需求。作为中国妇科第2大恶性肿瘤,其标准治疗是全子宫和双侧附件切除术,然而这会导致永久不孕。孕激素对早期子宫内膜癌和非典型子宫内膜增生治疗效果良好且不会破坏生育力。保育患者的筛选标准已有指南给出推荐。口服醋酸甲地孕酮(megestrolacetate)、醋酸甲羟孕酮(medroxyprogesterone acetate)是目前最常用的保育方案,左炔诺孕酮(levonorgestrel)宫内节育器作为局部孕激素疗法同样不可忽视。此外,孕激素药物与二甲双胍(metformin)、促性腺激素释放激素激动剂等药物的联合使用研究正在不断开展。面对现有治疗方案的局限性,积极寻找治疗及预后标志物,探索治疗新方法同样重要。

, authors=李俊慜, 朱佳蕾, 汤静*, authorsList=李俊慜, 朱佳蕾, 汤静, authorCompany=null, correspAuthors=汤静, authorNote=

李俊慜,博士研究生,研究方向:妇产科临床药学。

, correspAuthorsNote=
汤静,主任药师,研究方向:妇产科临床药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=EoWqrtHrFRZ9SKZ0umHm5w==, magXml=exJifQ5qGNnj/M3OlhstEw==, pdfUrl=null, pdf=18EOEq0e6BIZ/egN4ux8VQ==, pdfFileSize=1602030, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=HjYz7Hshlusb3SWxHjdZpw==, mapNumber=null, fund=null)}, authors=[Author(id=1329835097794130455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835097869627929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835097794130455, language=EN, stringName=Junmin LI, firstName=Junmin, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835097949319706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835097794130455, language=CN, stringName=李俊慜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属妇产科医院药剂科,上海 200090, bio={"content":"

李俊慜,博士研究生,研究方向:妇产科临床药学。

"}, bioImg=null, bioContent=

李俊慜,博士研究生,研究方向:妇产科临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])]), Author(id=1329835098016428572, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835098096120350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098016428572, language=EN, stringName=Jialei ZHU, firstName=Jialei, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835098171617823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098016428572, language=CN, stringName=朱佳蕾, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属妇产科医院药剂科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])]), Author(id=1329835098230338081, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835098322612771, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098230338081, language=EN, stringName=Jing TANG, firstName=Jing, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835098435858980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098230338081, language=CN, stringName=汤静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=复旦大学附属妇产科医院药剂科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])])], keywords=[Keyword(id=1329835098561688101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=EN, orderNo=1, keyword=progesterone), Keyword(id=1329835098649768486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=EN, orderNo=2, keyword=endometrial cancer), Keyword(id=1329835098716877351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=EN, orderNo=3, keyword=atypical endometrial hyperplasia), Keyword(id=1329835098800763432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=EN, orderNo=4, keyword=fertility sparing treatment), Keyword(id=1329835098880455209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=CN, orderNo=1, keyword=孕激素), Keyword(id=1329835098955952682, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=CN, orderNo=2, keyword=子宫内膜癌), Keyword(id=1329835099023061547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=CN, orderNo=3, keyword=非典型子宫内膜增生), Keyword(id=1329835099085976108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, language=CN, orderNo=4, keyword=生育力保存)], refs=[Reference(id=1329835099287302702, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333): 1412-1428., articleTitle=null, refAbstract=null), Reference(id=1329835099350217263, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=中国抗癌协会妇科肿瘤专业委员会. 子宫内膜癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6): 501-512., articleTitle=null, refAbstract=null), Reference(id=1329835099408937520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Uccella S, Zorzato PC, Dababou S, et al. Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women[J]. Medicina (Kaunas), 2022, 58(9): 1256., articleTitle=null, refAbstract=null), Reference(id=1329835099480240689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Rodolakis A, Biliatis I, Morice P, et al. European society of gynecological oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients[J]. Int J Gynecol Cancer, 2015, 25(7): 1258-1265., articleTitle=null, refAbstract=null), Reference(id=1329835099538960946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, version 1. 2023, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(2): 181-209., articleTitle=null, refAbstract=null), Reference(id=1329835099601875507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Ronsini C, Mosca L, Iavarone I, et al. Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer[J]. Front Oncol, 2022, 12: 965029., articleTitle=null, refAbstract=null), Reference(id=1329835099660595764, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Fernandez-Montoli ME, Sabadell J, Contreras-Perez NA. Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer: a cochrane systematic review protocol[J]. Adv Ther, 2021, 38(5): 2717-2731., articleTitle=null, refAbstract=null), Reference(id=1329835099727704629, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023[J]. Int J Gynaecol Obstet, 2023, 162(2): 383-394., articleTitle=null, refAbstract=null), Reference(id=1329835099794813494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Rodolakis A, Scambia G, Planchamp F, et al. ESGO/ESHRE/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma[J]. Hum Reprod Open, 2023, 2023(1): hoac057., articleTitle=null, refAbstract=null), Reference(id=1329835101409620535, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=子宫内膜癌保留生育功能多学科诊疗中国专家共识编写组. 子宫内膜癌保留生育功能多学科诊疗中国专家共识[J]. 中华生殖与避孕杂志, 2023, 43(4): 346-356., articleTitle=null, refAbstract=null), Reference(id=1329835101497700920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu Z, Yang B, Shan W, et al. Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phaseⅡstudy[J]. Gynecol Oncol, 2023, 174: 133-141., articleTitle=null, refAbstract=null), Reference(id=1329835101560615481, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu Z, Yang B, Guan J, et al. Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phaseⅡtrial (ClinicalTrials. gov NCT03241914)[J]. J Gynecol Oncol, 2023, 34(1): e32., articleTitle=null, refAbstract=null), Reference(id=1329835101631918650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Lee AJ, Yang EJ, Kim NK, et al. Fertility-sparing hormonal treatment in patients with stageⅠendometrial cancer of grade 2 without myometrial invasion and grade 1—2 with superficial myometrial invasion: gynecologic oncology research investigators collaboration study (GORILLA-2001)[J]. Gynecol Oncol, 2023, 174: 106-113., articleTitle=null, refAbstract=null), Reference(id=1329835101694833211, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Roh HJ, Yoon HJ, Jeong DH, et al. Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer[J]. J Res Med Sci, 2021, 26: 48., articleTitle=null, refAbstract=null), Reference(id=1329835101753553468, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Mandelbaum RS, Ciccone MA, Nusbaum DJ, et al. Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy[J]. Am J Obstet Gynecol, 2020, 223(1): 103. e1-103. e13., articleTitle=null, refAbstract=null), Reference(id=1329835101820662333, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Marnach ML, Butler KA, Henry MR, et al. Oral progestogens versus levonorgestrel-releasing intrauterine system for treatment of endometrial intraepithelial neoplasia[J]. J Womens Health (Larchmt), 2017, 26(4): 368-373., articleTitle=null, refAbstract=null), Reference(id=1329835101879382590, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Tamauchi S, Kajiyama H, Utsumi F, et al. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer[J]. J Obstet Gynaecol Res, 2018, 44(1): 151-156., articleTitle=null, refAbstract=null), Reference(id=1329835101938102847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Yuk JS, Song JY, Lee JH, et al. Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis[J]. Ann Surg Oncol, 2017, 24(5): 1322-1329., articleTitle=null, refAbstract=null), Reference(id=1329835102021988928, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Abu Hashim H, Ghayaty E, El Rakhawy M. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials[J]. Am J Obstet Gynecol, 2015, 213(4): 469-478., articleTitle=null, refAbstract=null), Reference(id=1329835102110069313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Oishi M, Kasuga Y, Fukuma Y, et al. Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study[J]. Int J Clin Oncol, 2023, 28(4): 587-591., articleTitle=null, refAbstract=null), Reference(id=1329835102172983874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Mittermeier T, Farrant C, Wise MR. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia[J]. Cochrane Database Syst Rev, 2020, 9(9): CD012658., articleTitle=null, refAbstract=null), Reference(id=1329835102252675651, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Yuan F, Hu Y, Han X, et al. Metformin in combination with progesterone improves the pregnancy rate for patients with early endometrial cancer[J]. Contrast Media Mol Imaging, 2022, 2022: 1961016., articleTitle=null, refAbstract=null), Reference(id=1329835102361727556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang BY, Gulinazi Y, Du Y, et al. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial[J]. BJOG, 2020, 127(7): 848-857., articleTitle=null, refAbstract=null), Reference(id=1329835102424642117, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Mitsuhashi A, Kawasaki Y, Hori M, et al. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)[J]. Br Med J Open, 2020, 10(2): e035416., articleTitle=null, refAbstract=null), Reference(id=1329835102479168070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Mitsuhashi A, Habu Y, Kobayashi T, et al. Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients[J]. J Gynecol Oncol, 2019, 30(6): e90., articleTitle=null, refAbstract=null), Reference(id=1329835102546276935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Jing CY, Li SN, Shan BE, et al. Hysteroscopic curettage followed by megestrol acetate plus metformin as a fertility-sparing treatment for women with atypical endometrial hyperplasia or well-differentiated endometrioid endometrial carcinoma[J]. Clin Med Insights Oncol, 2022, 16: 11795549221110522., articleTitle=null, refAbstract=null), Reference(id=1329835102634357320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhao XL, Du ZQ, Zhang X, et al. Fertility-preserving treatment in patients with early-stage endometrial cancer: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2021, 100(48): e27961., articleTitle=null, refAbstract=null), Reference(id=1329835102705660489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Masciullo V, Trivellizzi N, Zannoni G, et al. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate[J]. Am J Obstet Gynecol, 2021, 224(4): 408-410., articleTitle=null, refAbstract=null), Reference(id=1329835102768575050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Kuzel D, Lisa Z, Fanta M, et al. Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system[J]. Minim Invasive Ther Allied Technol, 2022, 31(4): 615-619., articleTitle=null, refAbstract=null), Reference(id=1329835102835683915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu Q, Lian Y, Chen L, et al. Alleviation of symptoms and improvement of endometrial receptivity following laparoscopic adenomyoma excision and secondary therapy with the levonorgestrel-releasing intrauterine system[J]. Reprod Sci, 2020, 27(6): 1259-1265., articleTitle=null, refAbstract=null), Reference(id=1329835102902792780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Cholakian D, Hacker K, Fader AN, et al. Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer[J]. Gynecol Oncol, 2016, 140(2): 234-238., articleTitle=null, refAbstract=null), Reference(id=1329835102961513037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Matsuo K, Mandelbaum RS, Ciccone M, et al. Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia[J]. Int J Gynecol Cancer, 2020, 30(9): 1331-1339., articleTitle=null, refAbstract=null), Reference(id=1329835103037010510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Wei H, Pan N, Zhang W, et al. Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis[J]. J Gynecol Oncol, 2023, 34(2): e36., articleTitle=null, refAbstract=null), Reference(id=1329835103099925071, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Li M, Guo T, Cui R, et al. Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis[J]. Cancer Manag Res, 2019, 11: 4005-4021., articleTitle=null, refAbstract=null), Reference(id=1329835103162839632, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Cho A, Lee S W, Park JY, et al. Continued medical treatment for persistent early endometrial cancer in young women[J]. Gynecol Oncol, 2021, 160(2): 413-417., articleTitle=null, refAbstract=null), Reference(id=1329835103225754193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Markowska A, Chudecka-Głaz A, Pityński K, et al. Endometrial cancer management in young women[J]. Cancers (Basel), 2022, 14(8): 1922., articleTitle=null, refAbstract=null), Reference(id=1329835103301251666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Okamura Y, Saito F, Takaishi K, et al. Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age[J]. Reprod Med Biol, 2017, 16(1): 67-71., articleTitle=null, refAbstract=null), Reference(id=1329835103380943443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Behrouzi R, Ryan NAJ, Barr CE, et al. Baseline serum HE4 but not tissue HE4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer[J]. Cancers (Basel), 2020, 12(2): 276., articleTitle=null, refAbstract=null), Reference(id=1329835103469023828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Li C, Bai Y, Yan L, et al. SPAG9 may be a potential prognostic marker of endometrial hyperplasia and grade 1 endometrioid adenocarcinoma treated with progestin[J]. Gynecol Obstet Invest, 2016, 81(3): 267-274., articleTitle=null, refAbstract=null), Reference(id=1329835103527744085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Dore M, Filoche S, Danielson K, et al. Characterisation of levonorgestrel-resistant endometrial cancer cells[J]. Cancer Manag Res, 2021, 13: 7871-7884., articleTitle=null, refAbstract=null), Reference(id=1329835103628407382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Peng H, Jiang J, Li X. Endometrial cancer following levonorgestrel-releasing intrauterine system insertion in young women with atypical hyperplasia: two case reports and literature review[J]. Reprod Sci, 2022, 29(11): 3278-3284., articleTitle=null, refAbstract=null), Reference(id=1329835103687127639, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang L, Lyu Q, Wu P, et al. RNA-seq and ATAC-seq analysis of CD163+ macrophage-induced progestin-insensitive endometrial cancer cells[J]. Cancer Med, 2023, 12(5): 5964-5978., articleTitle=null, refAbstract=null), Reference(id=1329835103750042200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Yunokawa M, Yoshida H, Watanabe R, et al. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer[J]. Cancer Chemother Pharmacol, 2017, 80(1): 127-134., articleTitle=null, refAbstract=null), Reference(id=1329835103817151065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu Y, Hu J, Lyu Q, et al. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway[J]. Stem Cell Res Ther, 2023, 14(1): 159., articleTitle=null, refAbstract=null), Reference(id=1329835103875871322, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang Z, Zhang M, Zhou J, et al. Genome-wide CRISPR screening reveals ADCK3 as a key regulator in sensitizing endometrial carcinoma cells to MPA therapy[J]. Br J Cancer, 2023, 129(4): 601-611., articleTitle=null, refAbstract=null), Reference(id=1329835103951368795, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Garzon S, Uccella S, Zorzato P C, et al. Fertility-sparing management for endometrial cancer: review of the literature[J]. Minerva Med, 2021, 112(1): 55-69., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329835099182445101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, awardId=201940153, language=CN, fundingSource=2019年度上海市卫生健康委员会卫生行业研究专项面上项目(201940153), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.02.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.02.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.02.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.02.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
孕激素在子宫内膜癌和非典型子宫内膜增生保留生育力中的应用
李俊慜 , 朱佳蕾 , 汤静 *
世界临床药物 | 医药专论 2024,45(2): 112-118
收起
收藏切换
世界临床药物 |医药专论 2024 , 45 (2) : 112 -118
孕激素在子宫内膜癌和非典型子宫内膜增生保留生育力中的应用
全屏
[Author(id=1329835097794130455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835097869627929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835097794130455, language=EN, stringName=Junmin LI, firstName=Junmin, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835097949319706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835097794130455, language=CN, stringName=李俊慜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属妇产科医院药剂科,上海 200090, bio={"content":"

李俊慜,博士研究生,研究方向:妇产科临床药学。

"}, bioImg=null, bioContent=

李俊慜,博士研究生,研究方向:妇产科临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])]), Author(id=1329835098016428572, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835098096120350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098016428572, language=EN, stringName=Jialei ZHU, firstName=Jialei, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835098171617823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098016428572, language=CN, stringName=朱佳蕾, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属妇产科医院药剂科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])]), Author(id=1329835098230338081, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835098322612771, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098230338081, language=EN, stringName=Jing TANG, firstName=Jing, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835098435858980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, authorId=1329835098230338081, language=CN, stringName=汤静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=复旦大学附属妇产科医院药剂科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835097689272850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, xref=null, ext=[AuthorCompanyExt(id=1329835097701855763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China), AuthorCompanyExt(id=1329835097714438677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835095424348687, companyId=1329835097689272850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属妇产科医院药剂科,上海 200090)])])]
李俊慜, 朱佳蕾, 汤静*
作者信息
  • 复旦大学附属妇产科医院药剂科,上海 200090
通讯作者:
汤静,主任药师,研究方向:妇产科临床药学。
作者简介:

李俊慜,博士研究生,研究方向:妇产科临床药学。

Application of progesterone in preserving fertility in endometrial cancer and atypical endometrial hyperplasia
Junmin LI, Jialei ZHU, Jing TANG*
Affiliations
  • Department of Pharmacy, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200090, China
出版时间: 2024-02-10 doi: 10.13683/j.wph.2024.02.002
文章导航
收藏切换

子宫内膜癌(endometrial cancer)和非典型子宫内膜增生(atypical endometrial hyperplasia)患者的发病逐渐年轻化,当前生育年龄又普遍延迟,使得这类患者对保留生育力的治疗产生重大需求。作为中国妇科第2大恶性肿瘤,其标准治疗是全子宫和双侧附件切除术,然而这会导致永久不孕。孕激素对早期子宫内膜癌和非典型子宫内膜增生治疗效果良好且不会破坏生育力。保育患者的筛选标准已有指南给出推荐。口服醋酸甲地孕酮(megestrolacetate)、醋酸甲羟孕酮(medroxyprogesterone acetate)是目前最常用的保育方案,左炔诺孕酮(levonorgestrel)宫内节育器作为局部孕激素疗法同样不可忽视。此外,孕激素药物与二甲双胍(metformin)、促性腺激素释放激素激动剂等药物的联合使用研究正在不断开展。面对现有治疗方案的局限性,积极寻找治疗及预后标志物,探索治疗新方法同样重要。

孕激素  /  子宫内膜癌  /  非典型子宫内膜增生  /  生育力保存

The onset of endometrial cancer and atypical endometrial hyperplasia is gradually becoming younger, and the current childbearing age is generally delayed, which makes these patients have a great demand for fertility sparing treatment. As the second most common gynecological malignancy in China, the standard treatment is total hysterectomy and bilateral adnexectomy, which leads to permanent infertility. Progesterone is effective in the treatment of early-stage endometrial cancer and atypical endometrial hyperplasia without destroying fertility. Screening criteria for these patients have been recommended in guidelines. Oral megestrol acetate and medroxyprogesterone acetate are the most commonly used fertility sparing treatments, levonorgestrel-releasing intrauterine devices, as a local progesterone therapy, can not be ignored. In addition, studies on the combination of progesterone drugs with metformin and gonadotropin releasing hormone agonist are being carried out. Facing the limitations of existing treatment options, it is equally important to actively search for therapeutic and prognostic markers, and explore new treatment methods.

progesterone  /  endometrial cancer  /  atypical endometrial hyperplasia  /  fertility sparing treatment
李俊慜, 朱佳蕾, 汤静. 孕激素在子宫内膜癌和非典型子宫内膜增生保留生育力中的应用. 世界临床药物, 2024 , 45 (2) : 112 -118 . DOI: 10.13683/j.wph.2024.02.002
Junmin LI, Jialei ZHU, Jing TANG. Application of progesterone in preserving fertility in endometrial cancer and atypical endometrial hyperplasia[J]. World Clinical Drug, 2024 , 45 (2) : 112 -118 . DOI: 10.13683/j.wph.2024.02.002
  • 2019年度上海市卫生健康委员会卫生行业研究专项面上项目(201940153)
参考文献 引证文献
排序方式:
[1]
Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333): 1412-1428.
[2]
中国抗癌协会妇科肿瘤专业委员会. 子宫内膜癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6): 501-512.
[3]
Uccella S, Zorzato PC, Dababou S, et al. Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women[J]. Medicina (Kaunas), 2022, 58(9): 1256.
[4]
Rodolakis A, Biliatis I, Morice P, et al. European society of gynecological oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients[J]. Int J Gynecol Cancer, 2015, 25(7): 1258-1265.
[5]
Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, version 1. 2023, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(2): 181-209.
[6]
Ronsini C, Mosca L, Iavarone I, et al. Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer[J]. Front Oncol, 2022, 12: 965029.
[7]
Fernandez-Montoli ME, Sabadell J, Contreras-Perez NA. Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer: a cochrane systematic review protocol[J]. Adv Ther, 2021, 38(5): 2717-2731.
[8]
Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023[J]. Int J Gynaecol Obstet, 2023, 162(2): 383-394.
[9]
Rodolakis A, Scambia G, Planchamp F, et al. ESGO/ESHRE/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma[J]. Hum Reprod Open, 2023, 2023(1): hoac057.
[10]
子宫内膜癌保留生育功能多学科诊疗中国专家共识编写组. 子宫内膜癌保留生育功能多学科诊疗中国专家共识[J]. 中华生殖与避孕杂志, 2023, 43(4): 346-356.
[11]
Xu Z, Yang B, Shan W, et al. Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phaseⅡstudy[J]. Gynecol Oncol, 2023, 174: 133-141.
[12]
Xu Z, Yang B, Guan J, et al. Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phaseⅡtrial (ClinicalTrials. gov NCT03241914)[J]. J Gynecol Oncol, 2023, 34(1): e32.
[13]
Lee AJ, Yang EJ, Kim NK, et al. Fertility-sparing hormonal treatment in patients with stageⅠendometrial cancer of grade 2 without myometrial invasion and grade 1—2 with superficial myometrial invasion: gynecologic oncology research investigators collaboration study (GORILLA-2001)[J]. Gynecol Oncol, 2023, 174: 106-113.
[14]
Roh HJ, Yoon HJ, Jeong DH, et al. Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer[J]. J Res Med Sci, 2021, 26: 48.
[15]
Mandelbaum RS, Ciccone MA, Nusbaum DJ, et al. Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy[J]. Am J Obstet Gynecol, 2020, 223(1): 103. e1-103. e13.
[16]
Marnach ML, Butler KA, Henry MR, et al. Oral progestogens versus levonorgestrel-releasing intrauterine system for treatment of endometrial intraepithelial neoplasia[J]. J Womens Health (Larchmt), 2017, 26(4): 368-373.
[17]
Tamauchi S, Kajiyama H, Utsumi F, et al. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer[J]. J Obstet Gynaecol Res, 2018, 44(1): 151-156.
[18]
Yuk JS, Song JY, Lee JH, et al. Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis[J]. Ann Surg Oncol, 2017, 24(5): 1322-1329.
[19]
Abu Hashim H, Ghayaty E, El Rakhawy M. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials[J]. Am J Obstet Gynecol, 2015, 213(4): 469-478.
[20]
Oishi M, Kasuga Y, Fukuma Y, et al. Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study[J]. Int J Clin Oncol, 2023, 28(4): 587-591.
[21]
Mittermeier T, Farrant C, Wise MR. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia[J]. Cochrane Database Syst Rev, 2020, 9(9): CD012658.
[22]
Yuan F, Hu Y, Han X, et al. Metformin in combination with progesterone improves the pregnancy rate for patients with early endometrial cancer[J]. Contrast Media Mol Imaging, 2022, 2022: 1961016.
[23]
Yang BY, Gulinazi Y, Du Y, et al. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial[J]. BJOG, 2020, 127(7): 848-857.
[24]
Mitsuhashi A, Kawasaki Y, Hori M, et al. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)[J]. Br Med J Open, 2020, 10(2): e035416.
[25]
Mitsuhashi A, Habu Y, Kobayashi T, et al. Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients[J]. J Gynecol Oncol, 2019, 30(6): e90.
[26]
Jing CY, Li SN, Shan BE, et al. Hysteroscopic curettage followed by megestrol acetate plus metformin as a fertility-sparing treatment for women with atypical endometrial hyperplasia or well-differentiated endometrioid endometrial carcinoma[J]. Clin Med Insights Oncol, 2022, 16: 11795549221110522.
[27]
Zhao XL, Du ZQ, Zhang X, et al. Fertility-preserving treatment in patients with early-stage endometrial cancer: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2021, 100(48): e27961.
[28]
Masciullo V, Trivellizzi N, Zannoni G, et al. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate[J]. Am J Obstet Gynecol, 2021, 224(4): 408-410.
[29]
Kuzel D, Lisa Z, Fanta M, et al. Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system[J]. Minim Invasive Ther Allied Technol, 2022, 31(4): 615-619.
[30]
Wu Q, Lian Y, Chen L, et al. Alleviation of symptoms and improvement of endometrial receptivity following laparoscopic adenomyoma excision and secondary therapy with the levonorgestrel-releasing intrauterine system[J]. Reprod Sci, 2020, 27(6): 1259-1265.
[31]
Cholakian D, Hacker K, Fader AN, et al. Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer[J]. Gynecol Oncol, 2016, 140(2): 234-238.
[32]
Matsuo K, Mandelbaum RS, Ciccone M, et al. Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia[J]. Int J Gynecol Cancer, 2020, 30(9): 1331-1339.
[33]
Wei H, Pan N, Zhang W, et al. Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis[J]. J Gynecol Oncol, 2023, 34(2): e36.
[34]
Li M, Guo T, Cui R, et al. Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis[J]. Cancer Manag Res, 2019, 11: 4005-4021.
[35]
Cho A, Lee S W, Park JY, et al. Continued medical treatment for persistent early endometrial cancer in young women[J]. Gynecol Oncol, 2021, 160(2): 413-417.
[36]
Markowska A, Chudecka-Głaz A, Pityński K, et al. Endometrial cancer management in young women[J]. Cancers (Basel), 2022, 14(8): 1922.
[37]
Okamura Y, Saito F, Takaishi K, et al. Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age[J]. Reprod Med Biol, 2017, 16(1): 67-71.
[38]
Behrouzi R, Ryan NAJ, Barr CE, et al. Baseline serum HE4 but not tissue HE4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer[J]. Cancers (Basel), 2020, 12(2): 276.
[39]
Li C, Bai Y, Yan L, et al. SPAG9 may be a potential prognostic marker of endometrial hyperplasia and grade 1 endometrioid adenocarcinoma treated with progestin[J]. Gynecol Obstet Invest, 2016, 81(3): 267-274.
[40]
Dore M, Filoche S, Danielson K, et al. Characterisation of levonorgestrel-resistant endometrial cancer cells[J]. Cancer Manag Res, 2021, 13: 7871-7884.
[41]
Peng H, Jiang J, Li X. Endometrial cancer following levonorgestrel-releasing intrauterine system insertion in young women with atypical hyperplasia: two case reports and literature review[J]. Reprod Sci, 2022, 29(11): 3278-3284.
[42]
Wang L, Lyu Q, Wu P, et al. RNA-seq and ATAC-seq analysis of CD163+ macrophage-induced progestin-insensitive endometrial cancer cells[J]. Cancer Med, 2023, 12(5): 5964-5978.
[43]
Yunokawa M, Yoshida H, Watanabe R, et al. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer[J]. Cancer Chemother Pharmacol, 2017, 80(1): 127-134.
[44]
Xu Y, Hu J, Lyu Q, et al. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway[J]. Stem Cell Res Ther, 2023, 14(1): 159.
[45]
Zhang Z, Zhang M, Zhou J, et al. Genome-wide CRISPR screening reveals ADCK3 as a key regulator in sensitizing endometrial carcinoma cells to MPA therapy[J]. Br J Cancer, 2023, 129(4): 601-611.
[46]
Garzon S, Uccella S, Zorzato P C, et al. Fertility-sparing management for endometrial cancer: review of the literature[J]. Minerva Med, 2021, 112(1): 55-69.
2024年第45卷第2期
26
7
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.02.002
  • 接收时间:2023-08-21
  • 首发时间:2026-11-18
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-08-21
基金
2019年度上海市卫生健康委员会卫生行业研究专项面上项目(201940153)
作者信息
    复旦大学附属妇产科医院药剂科,上海 200090

通讯作者:

汤静,主任药师,研究方向:妇产科临床药学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.02.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏